Delivery Order SPE2DB22D1202-SPE2DB25FVKS8
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,689.24 to AmerisourceBergen Drug Corp for Pyridoxine 100 mg/mL vials on September 8, 2025, with completion scheduled for September 9, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,120.23 to AmerisourceBergen Drug Corp for the supply of Pyridoxine 100 mg/mL vials. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,689.28 for Pyridoxine Hydrochloride (Vitamin B6) by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract utilizes standard...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,686.61 to AmerisourceBergen Drug Corp on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The contract falls under the Pharmaceutical Prime Vendor Global Program framework, which supports federal medical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,140.36 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a competitive, non-set-aside procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,580.20 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract, issued under a competitive process with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $87,321.50 to AmerisourceBergen Drug Corp on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order will be performed at AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $154,727.82 to AmerisourceBergen Drug Corp on August 18, 2025, with ultimate completion by August 19, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was competitively procured without set-aside designation and is being performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $3,471.02 to AmerisourceBergen Drug Corp for the supply of Aponvie 32 mg/4.4 mL vials. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,321.32 on July 25, 2025, for the supply of Abyrysvo vial with diluent syringes. This firm fixed price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The contract was competitively awarded with no set-aside designation and will be performed...